News
INPI and ANVISA: legitimate reasons for the disuse of pharmaceutical brands

Lawyer Natália Maranhão, by Gusmão & Labrunie, addressed issues related to the disuse of pharmaceutical brands and the tendency towards harmonization of decisions between INPI and ANVISA in an article published in Migalhas. To learn more, visit: http://bit.ly/35bs76m

Créditos: Natália Maranhão